NIFTY:
Nifty opened at 17297.20 with a gap up of 75 points. The index slowly drifted downwards in a sideways manner and recorded its intraday low at 17235.70. The index repeatedly found intraday support around 17250 in the first half and finally broke out. Prices have rallied almost 100 points and recorded its intraday high at 17343.65. The index finally closed at 17325.30 near its intraday highs w it h a ga in of 103.30 points or 0.60% up. The PHARMA and FINANCIAL outperformed today and closed with a gain of more than 1%.MEDIA and OIL GAS underperformed today and closed wit h a loss. FMCG and AUTO ended almost on a flat note.
It was a narrow range day today where prices have moved within a range of just 108 points and ended with a gain. A trading range inside 17000 – 17500 remained intact so far. Today’s narrow range indicates a sharp move is ahead. Since the short-term trend is up, we assume that the move may come on the upside. The short term uptrend will remain up as far as prices are trading above the support around 17000. Prices have been locked within the range for the last eight trading days and the range appeared after a sharp upside move of more than 11% from its swing lows. We may see a breakout soon here.
BANK NIFTY:
BANK NIFTY opened at 35931.55 with a gap up of 182 points. The index moved down from the beginning, filled the gap and moved down further to record its intraday low at 35506.55. Prices then bounced up and came close to its early morning and intraday highs recorded at 35977.20. The index finally closed at 35923.90 wit h a gain of 174 points. PSU and PVT BANKS both indices have performed well today, saw an upside move and closes wit h a gain of 1.22% & 0.70% respectively.
A trading range inside 35500 – 36500 remained intact and prices have repeatedly found support around 35500 from the last four trading days. We may see a breakout soon here.
TECHNICAL PICKS
| COMPANY NAME | CMP | B/S | RATIONALE+ |
| NAUKRI | 4493 | BUY | The stock is on the verge of giving the breakout on the intraday as well as the daily chart. The stock can be bought with a stop loss of 4450 and for the target of 4570. |
| ZEE | 285 | SELL | The immediate trend of the script is bearish. There is a negative cross over of moving averages as well as of the indicators therefore it can be sell below 284 with a stop loss of 288 and target of 280. |
DERIVATIVE PICKS
| Stock Name | Strike Price | Buy/Sell | CMP | Initiation | Stop Loss | Target | Remarks |
| SUNPHARMA | 920 CE | BUY | 4.55 | CMP | 1 | 10 | OI Increase |
| Long Buildup | Short Buildup | |||||||||
| Stocks | Price | Price% | OI % | OI | Stocks | Price | Price% | OI % | OI | |
| GAIL.Mar 31 | 152.85 | 0.1 | 12.38 | 27639100 | HEROMOTOCO.Mar 31 | 2222.85 | -6.89 | 5.33 | 2015700 | |
| MIDCPNIFTY.Mar 29 | 7196.3 | 0.14 | 18.18 | 975 | GSPL.Mar 31 | 253.1 | -2.45 | 0.34 | 2031500 | |
| DABUR.Mar 31 | 517.45 | 0.15 | 9.48 | 9541250 | AUROPHARMA.Mar 31 | 694.95 | -2.02 | 5.25 | 9284250 | |
| TITAN.Mar 31 | 2547.2 | 0.25 | 4.97 | 3681000 | CONCOR.Mar 31 | 649.55 | -1.88 | 4.61 | 4299200 | |
| TATACONSUM.Mar 31 | 744.4 | 0.34 | 6.42 | 6511725 | STAR.Mar 31 | 352.8 | -1.66 | 0.42 | 3004200 | |
| Short Covering | Long Unwinding | |||||||||
| UPL.Mar 31 | 784 | 0.06 | -8.15 | 10800400 | ONGC.Mar 31 | 171.1 | -2.98 | -4.86 | 30723000 | |
| ABCAPITAL.Mar 31 | 107.75 | 0.14 | -5.62 | 9746000 | COALINDIA.Mar 31 | 186.25 | -2.79 | -10.73 | 23419200 | |
| APLLTD.Mar 31 | 764.1 | 0.16 | -7.03 | 1360100 | ZEEL.Mar 31 | 282.95 | -2.53 | -0.85 | 33006000 | |
| ASHOKLEY.Mar 31 | 114.65 | 0.17 | -18.9 | 22014000 | IDEA.Mar 31 | 9.85 | -2.48 | -8.74 | 4.17E+08 | |
| HINDALCO.Mar 31 | 629.8 | 0.18 | -1.51 | 25076525 | L&TFH.Mar 31 | 82.7 | -2.13 | -41.74 | 16866360 | |
TOP DELIVERY PERCENTAGE
| Stocks | Price | %Chg | Total Qty | Delivery | Del % | % Change | ||||
| Sectors | Price | Change % | Quantity | |||||||
| Honeywell Auto India Ltd | 38964.9 | 0.95 | 4721 | 0 | 76.72 | Nifty50 | 17325.3 | 0.6 | 77730 | |
| Gmr Infrastructure Limit | 36.7 | 2.23 | 16891895 | 0 | 75.33 | Niftybank | 35847.4 | 0.38 | 77730 | |
| United Spirits Limited | 859.6 | -1.43 | 1498901 | 0 | 69.82 | Nifty it | 36146.75 | 0.34 | 77730 | |
| Hdfc Ltd. | 2337.35 | 3.05 | 3202852 | 0 | 68.44 | India Vix | 21.3 | -5.79 | 77730 | |
| Marico Limited | 482.5 | 1.64 | 861768 | 0 | 68 | Nifty Fmcg | 35640.15 | -0.05 | 77730 | |
| Hcl Technologies Ltd. | 1167.7 | 0.32 | 2443230 | 0 | 67.42 | Nifty Pharma | 13771.4 | 1.54 | 77730 | |
| Torrent Pharma Ltd. | 2809.9 | 2.99 | 265373 | 0 | 67.09 | Nifty Realty | 455.4 | 0.98 | 77730 | |
| Aarti Industries Ltd. | 922.35 | 1.63 | 710079 | 0 | 66.73 | Nifty Psu Bank | 2714.2 | -0.83 | 77730 | |
| United Breweries Limited | 1407.45 | -0.66 | 276278 | 0 | 66.49 | Nifty Auto | 10416.25 | -0.05 | 77730 | |
| Power Grid Corporation o | 211.3 | -0.47 | 7852887 | 0 | 63.27 | Nifty Metal | 6571.85 | 0.19 | 77730 | |
| Grasim Ind Ltd. | 1623.7 | 0.79 | 1737040 | 0 | 62.69 | Nifty Media | 2307.95 | -1.22 | 77730 | |
UPCOMING ECONOMIC DATA
| Domestic International | |
| INR: Federal Fiscal Deficit (Feb) on 31th March, 2022
INR: Infrastructure Output (YoY) (Feb) on 31st Match, 2022 |
•USD: ADP Nonfarm Employment Change (Mar) on 30th March, 2022
•USD: GDP (QoQ) (Q4) on 30th March, 2022 |
NEWS UPDATES
- Alembic Pharmaceuticals has acquired the balance 40 per cent stake in Aleor Dermaceuticals from its joint venture partner Orbicular Pharma for an undisclosed sum. The move is aimed at strengthening its skin-related manufacturing and marketing footprint.
- L&T Technology Services (LLTS), the pure play engineering services unit of the L&T Group is betting big on Meta. The company is setting up a Centre of Excellence for Metaverse as well as creating a business unit for Meta. The CoE will be launched by July-August. Amit Chadha, CEO & MD, LTTS shared that while the Coronavirus (Covid-19) pandemic accelerated digital transformation of the business across the globe, the confluence of 5G, digital products, AI and digital manufacturing is finally merging the physical and digital to create a plausible phygital universe.
- Coal India Ltd is set to post its highest-ever production during the 2021-22 fiscal, topping the 620-million-tonne mark and bucking two years of a declining streak of annual output, a company official said. The miner’s production for the current fiscal stood at 614.4 million tonnes as of March 28.
- Ruchi Soya on Tuesday announced on Tuesday that the Board meeting to determine issue price, anchor investor issue price of FPO has been rescheduled to March 31. Shares of Ruchi Soya surged on Tuesday after the company, through newspaper advertisements, clarified that the SMSes pertaining to investments in its follow-on public offering (FPO) have not been issued by the company or its promoters.
Source: Economic Times, Indian Express ,Business Today, Livemint, Business Standard, Bloomberg Quint.
BOARD MEETINGS
| Company Name | Purpose | Ex-Date | Company Name | Purpose | Ex-Date |
| 3MINDIA | General | 30-Mar-22 | ASIACAP | General | 31-Mar-22 |
| INANI | General | 30-Mar-22 | BHARATAGRI | General | 31-Mar-22 |
| JINDCAP | General | 30-Mar-22 | BMW | Interim Dividend | 31-Mar-22 |
| KREONFIN | General | 30-Mar-22 | CITYONLINE | General | 31-Mar-22 |
| LELAVOIR | General | 30-Mar-22 | CRESSAN | Issue Of Warrants | 31-Mar-22 |
| LLOYDSME | General | 30-Mar-22 | CRSTCHM | General | 31-Mar-22 |
| MEWATZI | General | 30-Mar-22 | EASEMYTRIP | General | 31-Mar-22 |
| MRCEXIM | General | 30-Mar-22 | EASTRED | General | 31-Mar-22 |
| PARSHINV | General | 30-Mar-22 | GAIL | Buy Back of Shares;General | 31-Mar-22 |
| SCANPGEOM | General | 30-Mar-22 | GIANLIFE | Bonus issue;General | 31-Mar-22 |
| SEJAL | General | 30-Mar-22 | KHAITANLTD | General | 31-Mar-22 |
| SUPRAP | General | 30-Mar-22 | KINGSINFR | General | 31-Mar-22 |
| ZDHJERK | General | 30-Mar-22 | MARIS | General | 31-Mar-22 |
CORPORATE ACTION
| Company Name | Ex-Date | Purpose | Company Name | Ex-Date | Purpose |
| 7NR | 30-Mar-22 | Stock Split From Rs.10/- to Rs.1/- | NEPTEXP | 30-Mar-22 | Amalgamation |
| AMBUJACEM | 30-Mar-22 | Final Dividend – Rs. – 6.3000 | NGIL | 30-Mar-22 | Right Issue of Equity Shares |
| CRISIL | 30-Mar-22 | Final Dividend – Rs. – 15.0000 | NORTHPR | 30-Mar-22 | Amalgamation |
| CRISIL | 30-Mar-22 | Special Dividend – Rs. – 7.0000 | SBICARD | 30-Mar-22 | Interim Dividend – Rs. – 2.5000 |
| DHAMPURSUG | 30-Mar-22 | Interim Dividend – Rs. – 6.0000 | TEATIME | 30-Mar-22 | Amalgamation |
| GILADAFINS | 30-Mar-22 | Stock Split From Rs.10/- to Rs.5/- | FLUOROCHEM | 31-Mar-22 | Interim Dividend – Rs. – 2.0000 |
| GILADAFINS | 30-Mar-22 | Bonus issue 1:1 | ACC | 04-Apr-22 | Final Dividend – Rs. – 58.0000 |
| MAKERSL | 30-Mar-22 | Right Issue of Equity Shares | KAMAHOLD | 04-Apr-22 | Interim Dividend – Rs. – 111.0000 |
Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014
Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL